| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |